INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 195 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $204,000 | -67.5% | 1,616 | -63.3% | 0.01% | -60.7% |
| Q2 2016 | $627,000 | +200.0% | 4,400 | +31328.6% | 0.03% | +300.0% |
| Q4 2015 | $209,000 | -3.7% | 14 | -98.4% | 0.01% | +75.0% |
| Q2 2015 | $217,000 | -4.0% | 900 | +12.5% | 0.00% | -42.9% |
| Q1 2015 | $226,000 | -68.6% | 800 | -73.7% | 0.01% | -69.6% |
| Q3 2014 | $720,000 | -12.4% | 3,044 | -12.4% | 0.02% | -39.5% |
| Q2 2014 | $822,000 | – | 3,474 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |